Cargando…
A Case of Drug-Induced Interstitial Lung Disease Caused by Epirubicin and Cyclophosphamide Therapy Before Breast Cancer Surgery
We report a case of drug-induced interstitial lung disease (ILD) caused by epirubicin and cyclophosphamide (EC) therapy in a patient with breast cancer. The patient suffered from a dry cough, fever, and exertional dyspnea after two courses of EC therapy. Antibiotic treatment did not improve her symp...
Autores principales: | Egashira, Ayaka, Yanagihara, Toyoshi, Ogo, Naruhiko, Asoh, Tatsuma, Maeyama, Takashige |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8712254/ https://www.ncbi.nlm.nih.gov/pubmed/34976548 http://dx.doi.org/10.7759/cureus.20676 |
Ejemplares similares
-
Three cases of sequential treatment with nintedanib following pulsed-dose corticosteroids for acute exacerbation of interstitial lung diseases
por: Nakashima, Kazuki, et al.
Publicado: (2021) -
Tacrolimus Treatment for Post-COVID-19 Interstitial Lung Disease
por: Ohgushi, Migiwa, et al.
Publicado: (2021) -
A fatal case of diffuse alveolar hemorrhage complicated by rheumatoid arthritis
por: Nakashima, Kazuki, et al.
Publicado: (2021) -
A Rare Case of Pembrolizumab-Induced Dermatomyositis in a Patient with Cancer of Unknown Primary Origin
por: Takatsuki, Kensaku, et al.
Publicado: (2021) -
Successful treatment with mepolizumab for allergic bronchopulmonary mycosis complicated with bilateral septic arthritis of the knee joints caused by Methicillin-resistant Staphylococcus aureus
por: Yanagihara, Toyoshi, et al.
Publicado: (2020)